A safety review of JAK inhibitors for managing alopecia areata.

Thanomkitti K, Spagnolini S, Tosti A

DOI: 10.1080/14740338.2026.2734464
Published: 2026 Sep 20
Container: Expert opinion on drug safety
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1080/14740338.2026.2734464,
  title = {A safety review of JAK inhibitors for managing alopecia areata.},
  author = {Thanomkitti K and Spagnolini S and Tosti A},
  year = {2026},
  journal = {Expert opinion on drug safety},
  doi = {10.1080/14740338.2026.2734464},
  url = {https://doi.org/10.1080/14740338.2026.2734464}
}

RIS

TY  - JOUR
TI  - A safety review of JAK inhibitors for managing alopecia areata.
AU  - Thanomkitti K
AU  - Spagnolini S
AU  - Tosti A
PY  - 2026
JO  - Expert opinion on drug safety
DO  - 10.1080/14740338.2026.2734464
UR  - https://doi.org/10.1080/14740338.2026.2734464
ER  -

APA

K, T., S, S., & A, T. (2026). A safety review of JAK inhibitors for managing alopecia areata.. Expert opinion on drug safety. https://doi.org/10.1080/14740338.2026.2734464

Source records

pubmed · retrieved 2026-09-25T18:35:06.819Z